Linked Life Data

8326553

Source:http://linkedlifedata.com/resource/pubmed/id/8326553

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2 Pt 1
pubmed:dateCreated
1993-8-12
pubmed:abstractText
The use of topical agents in the treatment and prophylaxis of transitional cell carcinoma of the bladder is well described. Several physicians have reported the use of these materials in the upper urinary tract for treatment of transitional cell carcinoma. We present our treatment protocol using mitomycin C as topical therapy following endoscopic resection of superficial urothelial tumors of the renal pelvis or ureter. A total of 7 patients was treated during the last 4 years. No systemic side effects due to perfusion with mitomycin C occurred. We believe that our treatment method provides a safe means of delivering topical agents to the upper urinary tract and suggest its use when such treatment is believed to be necessary.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-5347
pubmed:author
pubmed:issnType
Print
pubmed:volume
150
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
324-5
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
pubmed:affiliation
Department of Urology, University of Southern California Medical Center, Los Angeles.
pubmed:publicationType
Journal Article